3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Burkitt Lymphoma
1
Anus Neoplasms
1
Interventions
pembrolizumab
28
Paclitaxel
24
Carboplatin
19
Bevacizumab
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
Doxorubicin
8
Cisplatin
8
Biopsy
8
olaparib
7
lenvatinib
7
Taxes
7
Letrozole
7
Megestrol Acetate
6
Fulvestrant
6
durvalumab
5
dostarlimab
5
Nivolumab
5
Medroxyprogesterone Acetate
5
Gemcitabine
5
trastuzumab deruxtecan
4
abemaciclib
4
X-Rays
4
Trastuzumab
4
Tirzepatide
4
Progestins
4
Oxaliplatin
4
Immunoglobulin G
4
Fluorouracil
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Diphenhydramine
×
90 days
×
Clear all
No trials found.